Japan approves muscular dystrophy drug price of 300mn yen

2026-02-14 - 10:46

TOKYO -- An advisory panel to Japan's health minister decided Friday to allow public health insurance coverage for a gene therapy for muscular dystrophy beginning February 20 and set the drug's official price at about 304.97 million yen.